Temporomandibular Joint Osteoarthritis
6
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder
Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management
Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Joint (TMJ)
Microfragmented Adipose Tissue Injection Compared to Hyaluronic Acid for Treatment of Temporomandibular Joint Osteoarthritis
Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease
Tissue and Clinical Characterisation of Temporomandibular Joint Diseases